Protocol for a pilot randomised, double-blind, placebo-controlled trial for assessing the feasibility and efficacy of faecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: FAIS Trial
Background Irritable bowel syndrome (IBS) is a common chronic medical condition, in both children and adults. Despite the availability of effective (non)pharmacological treatments, symptoms persist in a significant amount of patients with IBS. Faecal microbiota transplantation (FMT) may be an effect...
Saved in:
| Main Authors: | Max Nieuwdorp, Judith Zeevenhooven, Clara Marieke Andrea de Bruijn, Arine Vlieger, Marc Alexander Benninga |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-02-01
|
| Series: | BMJ Paediatrics Open |
| Online Access: | https://bmjpaedsopen.bmj.com/content/4/1/e000689.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFICACY OF HYOSCINE BUTYLBROMIDE IN TREATMENT OF IRRITABLE BOWEL SYNDROME IN CHILDREN: PLACEBO-CONTROLLED TRIAL
by: K.V. Arifullina
Published: (2008-04-01) -
<i>Bifidobacterium adolescentis PRL2019</i> in Pediatric Irritable Bowel Syndrome: A Multicentric, Randomized, Double-Blind, Placebo-Controlled Trial
by: Valentina Giorgio, et al.
Published: (2025-03-01) -
Faecal microbiota transplantation in Crohn’s disease: an Australian randomised placebo-controlled trial protocol
by: Michael A Kamm, et al.
Published: (2025-04-01) -
Evaluation of Faecal Microbiota Following Probiotics in Infants of Mothers with Gestational Diabetes Mellitus Trial: Protocol for Double-Blind Placebo-Controlled Randomized Trial
by: Gayatri Athalye-Jape, et al.
Published: (2025-01-01) -
Chinese herbal formula Tongxie Yaofang granules for diarrhoea-predominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled, phase II trial
by: Nicola Robinson, et al.
Published: (2025-01-01)